The following information was taken from Abbott Laboratory’s financial statements. Abbott makes a variety of health care products and uses the indirect method to determine cash flows from operations:

Required Determine which of the preceding items would appear as a separate line-item on Abbott Laboratory s statement of cash flows. In each case, indicate whether the item is related to cash flows from operations, from investing activities, or from financing activities.

Transcribed Image Text:

Cost of goods sold Acquisitions of property, plant, and equipment Decrease in inventories Repayments of obligations under long-term leases Decrease in salaries payable $ 6,563,978 1,007,247 109,087 112,876 534,281 Gain on sale of land 271,986 Increase in receivables 181,085 Purchases of long-term investment securities 178,727 Repayments of long-term borrowings 234,848 Increase in accrued payables 154,873 Proceeds from short-term borrowings 196,487 Decrease in accounts payable 121,741 Proceeds from sales of property, plant, and equipment 23,878 Proceeds from the sale of long-term borrowings 381,848 Proceeds from sales of long-term investment securities 496,120 Decrease in other current assets 114,009 Purchases of common stock for treasury 607.598 Increase in prepaid expenses 34,875 Dividends paid Sales 488,413 10,978,387 Depreciation and amortization 427,782 Repayments of short-term borrowings 213,833 Increase in current assets 3,978,911 Proceeds from the exercise of executive stock options 74,027